Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2015

01.02.2015 | Clinical Study

A comparative study of intraventricular central neurocytomas and extraventricular neurocytomas

verfasst von: Zhongwei Xiong, Jianjian Zhang, Zhengwei Li, Jingjing Jiang, Qingdong Han, Shoujia Sun, Xiaolin Wu, Yu Wang, Ting Lei, Jincao Chen

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Similar histology and clinical behavior of both intraventricular central neurocytomas (CNs) and extraventricular neurocytomas (EVNs) may argue against the idea that EVNs were the distinct entity to distinguish from CNs in the 2007 World Health Organization classification. To explore respective characteristics and compare similarities and differences in CNs and EVNs, relevant clinical, radiological, operative and pathological data of 49 patients (35 CNs and 14 EVNs) in the Department of Neurosurgery at our hospital from 2005 to 2012 was reviewed and some comparisons between CNs and EVNs were conducted. The factors affecting posttreatment recurrence of CNs and EVNs were assessed by Cox regression analysis. In comparison, CNs showed a more typical clinical manifestation, and radiological and histopathological features, while EVNs demonstrated more malignant biological behavior, with higher MIB-1 index (p = 0.006), higher rate of atypia (p = 0.042), higher recurrence rate (p = 0.028), and shorter time to recurrence (p = 0.049). Subtotal resection was associated with higher rates of recurrence in both CNs (hazard ratio [HR] 6.16, p = 0.046) and EVNs (HR 5.26, p = 0.045), and atypia was also associated with a higher recurrence rate in CNs (HR 5.03, p = 0.042). CNs were thus easier to diagnose than EVNs, with typical clinical, radiological, and histopathological features, while the latter were more likely to show malignant biological behavior associated with atypia and recurrence. Total surgical resection is the optimal treatment choice for both CNs and EVNs, and patients with either CN or EVN with typical and/or totally resected lesions showed favorable clinical outcomes.
Literatur
1.
Zurück zum Zitat Hassoun J, Gambarelli D, Grisoli F et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 56(2):151–156PubMedCrossRef Hassoun J, Gambarelli D, Grisoli F et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 56(2):151–156PubMedCrossRef
2.
Zurück zum Zitat Hassoun J, Soylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3(3):297–306PubMedCrossRef Hassoun J, Soylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3(3):297–306PubMedCrossRef
3.
Zurück zum Zitat Kim DG, Kim JS, Chi JG et al (1996) Central neurocytoma: proliferative potential and biological behavior. J Neurosurg 84(5):742–747PubMedCrossRef Kim DG, Kim JS, Chi JG et al (1996) Central neurocytoma: proliferative potential and biological behavior. J Neurosurg 84(5):742–747PubMedCrossRef
4.
Zurück zum Zitat Valdueza JM, Westphal M, Vortmeyer A, Muller D, Padberg B, Herrmann HD (1996) Central neurocytoma: clinical, immunohistologic, and biologic findings of a human neuroglial progenitor tumor. Surg Neurol 45(1):49–56PubMedCrossRef Valdueza JM, Westphal M, Vortmeyer A, Muller D, Padberg B, Herrmann HD (1996) Central neurocytoma: clinical, immunohistologic, and biologic findings of a human neuroglial progenitor tumor. Surg Neurol 45(1):49–56PubMedCrossRef
5.
Zurück zum Zitat Chang KH, Han MH, Kim DG et al (1993) MR appearance of central neurocytoma. Acta Radiol 34(5):520–526PubMedCrossRef Chang KH, Han MH, Kim DG et al (1993) MR appearance of central neurocytoma. Acta Radiol 34(5):520–526PubMedCrossRef
6.
Zurück zum Zitat Ashkan K, Casey AT, D’Arrigo C, Harkness WF, Thomas DG (2000) Benign central neurocytoma. Cancer 89(5):1111–1120PubMedCrossRef Ashkan K, Casey AT, D’Arrigo C, Harkness WF, Thomas DG (2000) Benign central neurocytoma. Cancer 89(5):1111–1120PubMedCrossRef
7.
Zurück zum Zitat Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66(3):377–384PubMedCrossRef Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66(3):377–384PubMedCrossRef
8.
Zurück zum Zitat Sharma MC, Deb P, Sharma S, Sarkar C (2006) Neurocytoma: a comprehensive review. Neurosurg Rev 29(4):270–285 discussion 285PubMedCrossRef Sharma MC, Deb P, Sharma S, Sarkar C (2006) Neurocytoma: a comprehensive review. Neurosurg Rev 29(4):270–285 discussion 285PubMedCrossRef
9.
Zurück zum Zitat Brat DJ, Scheithauer BW, Eberhart CG, Burger PC (2001) Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 25(10):1252–1260PubMedCrossRef Brat DJ, Scheithauer BW, Eberhart CG, Burger PC (2001) Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 25(10):1252–1260PubMedCrossRef
10.
Zurück zum Zitat Rodriguez FJ, Mota RA, Scheithauer BW et al (2009) Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol 19(4):623–629PubMedCentralPubMedCrossRef Rodriguez FJ, Mota RA, Scheithauer BW et al (2009) Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol 19(4):623–629PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCentralPubMedCrossRef Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Brown DM, Karlovits S, Lee LH, Kim K, Rothfus WE, Brown HG (2001) Management of neurocytomas: case report and review of the literature. Am J Clin Oncol 24(3):272–278PubMedCrossRef Brown DM, Karlovits S, Lee LH, Kim K, Rothfus WE, Brown HG (2001) Management of neurocytomas: case report and review of the literature. Am J Clin Oncol 24(3):272–278PubMedCrossRef
13.
Zurück zum Zitat Giangaspero F, Cenacchi G, Losi L, Cerasoli S, Bisceglia M, Burger PC (1997) Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol 21(2):206–212PubMedCrossRef Giangaspero F, Cenacchi G, Losi L, Cerasoli S, Bisceglia M, Burger PC (1997) Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol 21(2):206–212PubMedCrossRef
14.
15.
Zurück zum Zitat Kane AJ, Sughrue ME, Rutkowski MJ et al (2012) Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg 116(2):349–354PubMedCrossRef Kane AJ, Sughrue ME, Rutkowski MJ et al (2012) Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg 116(2):349–354PubMedCrossRef
16.
Zurück zum Zitat Swinson BM, Friedman WA, Yachnis AT (2006) Pontine atypical neurocytoma: case report. Neurosurgery 58(5):E990 discussion E990PubMedCrossRef Swinson BM, Friedman WA, Yachnis AT (2006) Pontine atypical neurocytoma: case report. Neurosurgery 58(5):E990 discussion E990PubMedCrossRef
17.
Zurück zum Zitat Tatter SB, Borges LF, Louis DN (1995) Correction: central neurocytomas of the cervical spinal cord. J Neurosurg 82(4):706PubMed Tatter SB, Borges LF, Louis DN (1995) Correction: central neurocytomas of the cervical spinal cord. J Neurosurg 82(4):706PubMed
18.
Zurück zum Zitat Patil AS, Menon G, Easwer HV, Nair S (2013) Extraventricular neurocytoma, a comprehensive review. Acta Neurochir (Wien) 68(4):e206–e212 Patil AS, Menon G, Easwer HV, Nair S (2013) Extraventricular neurocytoma, a comprehensive review. Acta Neurochir (Wien) 68(4):e206–e212
19.
Zurück zum Zitat Yi KS, Sohn CH, Yun TJ, et al (2012) MR imaging findings of extraventricular neurocytoma: a series of ten patients confirmed by immunohistochemistry of IDH1 gene mutation. Acta Neurochir (Wien), 154(11):1973–1979; discussion 1980 Yi KS, Sohn CH, Yun TJ, et al (2012) MR imaging findings of extraventricular neurocytoma: a series of ten patients confirmed by immunohistochemistry of IDH1 gene mutation. Acta Neurochir (Wien), 154(11):1973–1979; discussion 1980
20.
Zurück zum Zitat Ueda F, Suzuki M, Matsui O, Uchiyama N (2007) Automated MR spectroscopy of intra- and extraventricular neurocytomas. Magn Reson Med Sci 6(2):75–81PubMedCrossRef Ueda F, Suzuki M, Matsui O, Uchiyama N (2007) Automated MR spectroscopy of intra- and extraventricular neurocytomas. Magn Reson Med Sci 6(2):75–81PubMedCrossRef
21.
Zurück zum Zitat von Deimling A, Janzer R, Kleihues P, Wiestler OD (1990) Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 79(5):473–479CrossRef von Deimling A, Janzer R, Kleihues P, Wiestler OD (1990) Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 79(5):473–479CrossRef
22.
Zurück zum Zitat Sharma MC, Rathore A, Karak AK, Sarkar C (1998) A study of proliferative markers in central neurocytoma. Pathology 30(4):355–359PubMedCrossRef Sharma MC, Rathore A, Karak AK, Sarkar C (1998) A study of proliferative markers in central neurocytoma. Pathology 30(4):355–359PubMedCrossRef
23.
Zurück zum Zitat Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P (1997) Atypical central neurocytoma. J Neuropathol Exp Neurol 56(5):551–556PubMedCrossRef Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P (1997) Atypical central neurocytoma. J Neuropathol Exp Neurol 56(5):551–556PubMedCrossRef
24.
Zurück zum Zitat Robbins P, Segal A, Narula S et al (1995) Central neurocytoma. A clinicopathological, immunohistochemical and ultrastructural study of 7 cases. Pathol Res Pract 191(2):100–111PubMedCrossRef Robbins P, Segal A, Narula S et al (1995) Central neurocytoma. A clinicopathological, immunohistochemical and ultrastructural study of 7 cases. Pathol Res Pract 191(2):100–111PubMedCrossRef
25.
Zurück zum Zitat Agarwal S, Sharma MC, Sarkar C et al (2011) Extraventricular neurocytomas: a morphological and histogenetic consideration. A study of six cases. Pathology 43(4):327–334PubMedCrossRef Agarwal S, Sharma MC, Sarkar C et al (2011) Extraventricular neurocytomas: a morphological and histogenetic consideration. A study of six cases. Pathology 43(4):327–334PubMedCrossRef
26.
Zurück zum Zitat Jay V, Edwards V, Hoving E et al (1999) Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses Case report. J Neurosurg 90(2):348–354PubMedCrossRef Jay V, Edwards V, Hoving E et al (1999) Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses Case report. J Neurosurg 90(2):348–354PubMedCrossRef
27.
Zurück zum Zitat Mut M, Guler-Tezel G, Lopes MB, Bilginer B, Ziyal I, Ozcan OE (2005) Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma. Clin Neuropathol 24(5):225–229PubMed Mut M, Guler-Tezel G, Lopes MB, Bilginer B, Ziyal I, Ozcan OE (2005) Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma. Clin Neuropathol 24(5):225–229PubMed
28.
Zurück zum Zitat Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61(11):947–955PubMed Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61(11):947–955PubMed
29.
Zurück zum Zitat Okada M, Yano H, Hirose Y et al (2011) Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas. Brain Tumor Pathol 28(2):157–161PubMedCrossRef Okada M, Yano H, Hirose Y et al (2011) Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas. Brain Tumor Pathol 28(2):157–161PubMedCrossRef
30.
Zurück zum Zitat Capper D, Reuss D, Schittenhelm J et al (2011) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 121(2):241–252PubMedCrossRef Capper D, Reuss D, Schittenhelm J et al (2011) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 121(2):241–252PubMedCrossRef
31.
Zurück zum Zitat Elek G, Slowik F, Eross L, Toth S, Szabo Z, Balint K (1999) Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination. Pathol Oncol Res 5(2):155–159PubMedCrossRef Elek G, Slowik F, Eross L, Toth S, Szabo Z, Balint K (1999) Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination. Pathol Oncol Res 5(2):155–159PubMedCrossRef
32.
Zurück zum Zitat Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 77(3):305–309PubMedCrossRef Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 77(3):305–309PubMedCrossRef
33.
Zurück zum Zitat Vasiljevic A, Francois P, Loundou A et al (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36(2):220–227PubMedCrossRef Vasiljevic A, Francois P, Loundou A et al (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36(2):220–227PubMedCrossRef
34.
Zurück zum Zitat Paek SH, Han JH, Kim JW et al (2008) Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 90(1):25–30PubMedCrossRef Paek SH, Han JH, Kim JW et al (2008) Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 90(1):25–30PubMedCrossRef
Metadaten
Titel
A comparative study of intraventricular central neurocytomas and extraventricular neurocytomas
verfasst von
Zhongwei Xiong
Jianjian Zhang
Zhengwei Li
Jingjing Jiang
Qingdong Han
Shoujia Sun
Xiaolin Wu
Yu Wang
Ting Lei
Jincao Chen
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2015
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-014-1659-z

Weitere Artikel der Ausgabe 3/2015

Journal of Neuro-Oncology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.